- Home
- TTNP vs KTTA Comparison
TTNP vs KTTA Comparison
Compare TTNP & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- KTTA
- Stock Information
- Founded
- TTNP 1991
- KTTA 2020
- Country
- TTNP United States
- KTTA United States
- Employees
- TTNP N/A
- KTTA 8
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- KTTA Health Care
- Exchange
- TTNP Nasdaq
- KTTA Nasdaq
- Market Cap
- TTNP 3.3M
- KTTA 3.4M
- IPO Year
- TTNP 1996
- KTTA 2021
- Fundamental
- Price
- TTNP $3.53
- KTTA $2.65
- Analyst Decision
- TTNP
- KTTA
- Analyst Count
- TTNP 0
- KTTA 0
- Target Price
- TTNP N/A
- KTTA N/A
- AVG Volume (30 Days)
- TTNP 28.0K
- KTTA 57.9K
- Earning Date
- TTNP 12-27-2024
- KTTA 11-13-2024
- Dividend Yield
- TTNP N/A
- KTTA N/A
- EPS Growth
- TTNP N/A
- KTTA N/A
- EPS
- TTNP N/A
- KTTA N/A
- Revenue
- TTNP $3,000.00
- KTTA N/A
- Revenue This Year
- TTNP N/A
- KTTA N/A
- Revenue Next Year
- TTNP N/A
- KTTA N/A
- P/E Ratio
- TTNP N/A
- KTTA N/A
- Revenue Growth
- TTNP N/A
- KTTA N/A
- 52 Week Low
- TTNP $3.24
- KTTA $2.57
- 52 Week High
- TTNP $14.80
- KTTA $9.40
- Technical
- Relative Strength Index (RSI)
- TTNP 40.85
- KTTA 34.15
- Support Level
- TTNP $3.25
- KTTA $2.57
- Resistance Level
- TTNP $3.85
- KTTA $3.07
- Average True Range (ATR)
- TTNP 0.36
- KTTA 0.21
- MACD
- TTNP -0.00
- KTTA 0.01
- Stochastic Oscillator
- TTNP 24.76
- KTTA 14.49
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.